The patient-specific nature of autologous cell therapies presents unique challenges that can best be addressed by a middle path between on-site and centralized manufacturing.

Thomas Kurian talks Google Cloud AI momentum with Gemini, $106 billion backlog, data platform BigQuery customers, and AI agents at Goldman Sachs event.

The real challenge is not whether we can build more housing; it’s whether we have the political will to do so with dignity ...